(IN BRIEF) Research presented at ESC Congress 2025 has shown that GLP-1 receptor agonists, used to treat patients with heart failure and preserved ejection fraction, not only reduce hospitalizations and improve outcomes but also cut the environmental footprint of healthcare. … Read the full press release
Posted in Business, Environment, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Science, Spain, Technology
Tagged carbon footprint of healthcare, environmental co-benefits, ESC Congress 2025, European Society of Cardiology, FLOW trial, GLP-1 receptor agonists, greenhouse gas emissions, healthcare sustainability, heart failure with preserved ejection fraction, HFpEF, Lahey Hospital & Medical Center, medical waste reduction, Sarju Ganatra, SELECT Trial, STEP HFpEF, Sustain Health Solutions, sustainability, Sustainable Healthcare
(IN BRIEF) A study presented at ESC Congress 2025 has found that a standard piston-based chest compression device is the only method able to achieve effective CPR depth in microgravity conditions, outperforming NASA’s current “handstand method” and other tested devices. … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Science, Spain, Technology
Tagged Air Zero G, automated chest compression, cardiac arrest in space, CHRU de Nancy, CNES, CPR in space, emergency medical kit, ESC Congress 2025, European Society of Cardiology, handstand method, international resuscitation guidelines, mechanical piston device, microgravity, Novespace, parabolic flight, resuscitation research, space medicine, space tourism, Université de Lorraine, Université de Paris
(IN BRIEF) Research presented at ESC Congress 2025 has shown that low fitness and older age independently increase the risk of arrhythmias in otherwise healthy adults. The study of 1,151 participants aged 40–65 revealed that reduced aerobic capacity was strongly … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Investment, Management, Marketing, Media, News, Science, Spain, Technology
Tagged aerobic fitness, aging, arrhythmias, atrial arrhythmias, cardiovascular disease, Cardiovascular risk, Chaim Sheba Medical Center, Dr Amit Moses, Early Detection, ECG monitoring, ESC Congress 2025, European Society of Cardiology, exercise and heart health, heart rhythm, irregular heartbeat, preventive cardiology, screening over 50s, ventricular arrhythmias
(IN BRIEF) Novartis will present 19 abstracts at the 2025 European Society of Cardiology (ESC) Congress in Madrid, showcasing new findings across its cardiovascular portfolio. Key highlights include two VictORION studies on Leqvio’s impact on quality of life and its … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged abelacimab, atrial fibrillation, AZALEA-TIMI 71, cardiovascular disease, cardiovascular pipeline therapies, Chagas disease, Entresto, ESC Congress 2025, European Society of Cardiology, heart failure, inclisiran, Leqvio, lipoprotein apheresis, lipoprotein(a), Lp(a)FRONTIERS APHERESIS trial, Novartis, PARACHUTE-HF trial, pelacarsen, Sacubitril Valsartan, VictORION studies, xRNA platform
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?